Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase Ib/II Open-Label Study of APVO436 in Combination with Venetoclax and Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia AML
Study Type: Treatment
Phase: I/II
NCTID: NCT06634394
Principal Investigator:
Tara Lin
A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma that Achieved a First Complete Remission CR1 Following Induction Therapy PTCL-STAT
Study Type: Treatment
Phase: III
NCTID: NCT06724237
Principal Investigator:
Marc Hoffmann
Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors FHWT
Study Type: Treatment
Phase: III
NCTID: NCT06401330
Principal Investigator:
Keith August
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects with Advanced Solid Tumors
Study Type: Treatment
Phase: I
NCTID: NCT06431594
Principal Investigator:
Andrea Jewell
A Phase I Study of Patient-Derived Multi-Tumor-Associated Antigen-Specific T-Cells MT-601 Administered to Patients with Relapsed or refractory Non-Hodgkin Lymphoma NHL [APOLLO]
Study Type: Treatment
Phase: I
NCTID: NCT05798897
Principal Investigator:
Haitham Abdelhakim
A Phase III/IV Randomized Open-Label Two Cohort Trial to Evaluate irAEs with Different Standard of Care Dosing Strategies of Pembrolizumab or Nivolumab
Study Type: Treatment
Phase: III
NCTID: NCT07174453
Principal Investigator:
Anup Kasi
A Phase 2 Study of Inotuzumab Ozogamicin NSC 772518 in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia B-ALL
Study Type: Treatment
Phase: II
NCTID: NCT02981628
Principal Investigator:
Kevin Ginn
A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer Lung-MAP Sub-Study
Study Type: Treatment
Phase: II
NCTID: NCT06031688
Principal Investigator:
Anusha Chidharla
Surgical Thromboprophylaxis Practices in Oncology Patients within the NCORP Network STOP-VTE
Study Type: Other
Phase: Feasibility/Pilot
NCTID: NCT07215624
Principal Investigator:
Luke Selby
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Study Type: Treatment
Phase: III
NCTID: NCT06585774
Principal Investigator:
Muhammad Umair Mushtaq